Navigation Links
Aware, Inc. Reports Second Quarter 2009 Financial Results
Date:8/1/2009

of 2009, excluding the effect of stock-based compensation, was $1.2 million, or $0.06 per diluted share. For the six months ended June 30, 2009, the company had a non-GAAP net loss, excluding the effect of stock-based compensation, of $2.9 million, or $0.13 per share.

Michael Tzannes, Aware's chief executive officer, said, "We are encouraged by the modest growth in our revenues this quarter. Our goal is to generate shareholder value by targeting growing portions of the biometrics, DSL test and home networking markets with a collection of technology, products and services."

Note: Aware's conference call will be broadcast live over the Internet today, July 30, 2009 at 5:00 p.m. Eastern Time. To listen to the call, please go to www.aware.com/ir. The conference call may also be heard by calling 719-325-2122 and referencing the confirmation number 2831084. A replay of the call will be archived on our website after the call.

About Aware

Aware is a leading technology and software supplier for the telecommunications and biometrics industries. For more than ten years, Aware has pioneered innovations at telecommunications standards-setting organizations and continues to develop and market DSL silicon intellectual property and test and diagnostics products. Its StratiPHY(tm) IP product line supports DSL standards, including ADSL2+ and VDSL2, and has been broadly licensed to leading semiconductor companies. Telecom equipment vendors and phone companies use Aware's DSL test and diagnostics modules and Dr. DSL(R) software to help provision DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware's interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border managem
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Aware, Inc. Announces Q209 Earnings Conference Call
2. Aware, Inc. Reports First Quarter 2009 Financial Results
3. Aware, Inc. Reports First Quarter 2009 Financial Results
4. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
5. Aware, Inc. Announces Q1 09 Earnings Conference Call
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
8. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
9. Aware, Inc. Commences Dutch Auction Tender Offer
10. Aware, Inc. Commences Dutch Auction Tender Offer
11. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...h 2009 - Bacteria possess an ingenious mechanism f...cks of the cell. This is the new finding of a team... a life sciences research institute in Flanders, B...l. The scientists made this discovery by modifying...coli . By means of this model organism, they have ...
(Date:11/20/2009)...the production of flax shives, and generated from ...ed to those which engulf fields in spring, can be ...d by two studies carried out by Spanish and Dutch ...e and Sustainable Energy Reviews . , "These studi...the production of bioethanol from two, as yet unex...
(Date:11/20/2009)...nergy Research Center (ERC) has been awarded a gra...elop methods of recovering and reusing the heat th...) compression process in a carbon capture system. ...carbon capture and sequestration, or storage (CCS)... gas, emitted into the atmosphere by coal-fired po...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Breakthrough in Alzheimers research 54318 1VJ Day marked with launch of POW project on Merseyside 54315 1VJ Day marked with launch of POW project on Merseyside 54315 2Australian filmmakers are stars of science film awards 9545 1Australian filmmakers are stars of science film awards 9545 2
...monly infects potatoes bears a striking resemblanc...er,s disease (AD), and researchers have used that ... onset of AD. , Studies in mice have demonstrated...believed to be a major AD contributor) to produce ...and improve cognitive function, possibly by promot...
...ie Mellon University researchers are urging compan... of dangerous carbon emissions that are responsibl..., Because there is no universally ...rint, dozens of carbon calculators have sprung up ...fusion and inaccurate information. In addition, ac...
... University of Virginia have discovered a switchin...gulating the sleep/wake cycles in mammals. , The ... in the eye are central to setting the rhythms of ...c nuclei, which regulates activity and rest cycles...es our understanding of how light input from the e...
Other Biology News:Carnegie Mellon urges industry to broaden carbon footprint calculations 2Light receptors in eye play key role in setting biological clock, study shows 2
(Date:11/19/2009)...Nov. 19 Danish Prince Joachim inau...anol plant in Kalundborg, Denmark, on Wednesday, N...st and largest 2nd generation ethanol demonstratio...e used in the plant,s innovative process for conve...co, was the first to market with commercial enzyme...
(Date:11/19/2009)....Y., Nov. 19 Dr. Mate Hidvegi, inv...onds to a press release issued on November 17 by B...for making false and self-serving statements about...Dr. Hidvegi stated from his office in Budapest, Hu...on Avemar does not apply to AveULTRA, www.aveult...
(Date:11/19/2009)...ov. 19 NeoStem, Inc. (NY...the following letter to its shareholders, discussi... of China Biopharmaceuticals Holdings, Inc. (CHBP)...n the People,s Republic of China. The merger gives... Pharmaceutical Co. Ltd., CHBP,s primary operating...
(Date:11/19/2009)..., Pa. and WALTHAM, Mass., Nov. 19 ...ources find that the leading driver of antibiotic ...ad-spectrum activity against gram-positive and gra...sms that can cause nosocomial pneumonia, surveyed ...y for agents that provide appropriate coverage aga...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
... Corporation,(Nasdaq: DNDN ) today announced tha...Eleventh Annual BIO CEO & Investor Conference ... 1:45 p.m. ET. , A live audio webcast of the p...r Relations section of the Dendreon website, http...to the live webcast, it will be archived on the,si...
... HIV-Resistant Immune Cells , , RICHMOND, Calif.,... ) announced today that its collaborators at the ...clinical trial to evaluate SB-728-T for the treatm...ger DNA-binding protein nuclease (ZFN) technology,...V infection to lead to an increase in CD4+ T-cell ...
... Black History Month is like none other. To mark ...Identity Experts launch Ancestry Education Project...ion and positive psychological development among t... Washington, DC (PRWEB) February 3, 2009 -- Afri...eered DNA-driven ancestry tracing for people of Af...
Other Biology Technology:Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 2Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 3Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 4Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 5Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 6Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS 7African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test 2African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test 3
T4 DNA Ligase (HC) from Invitrogen
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Somatostatin 28 Polyclonal Antibody, Unconjugated from Abcam
...ntial component of the COP9 signalosome complex (C...velopmental processes. The CSN complex is an essen...pathway by mediating the deneddylation of the cull...omplex is also involved in phosphorylation of p53/...
Biology Products: